Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial symbols : Ppruf save search
iOnctura initiates Phase Ib pancreatic cancer trial of next-generation autotaxin inhibitor IOA-289
Published: 2022-12-08 (Crawled : 10:00) - biospace.com/
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: 3.56%
H: 1.16%
C: -1.27%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -0.11%
H: 0.71%
C: 0.24%
ioa-289 trial cancer pancreatic
Opiant Pharmaceuticals Announces Completion of Enrollment in Phase 2 Clinical Trial of OPNT002, Nasal Naltrexone, in Patients with Alcohol Use Disorder
Published: 2022-10-06 (Crawled : 12:00) - globenewswire.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -3.87%
H: 3.16%
C: 0.67%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -2.41%
H: 0.51%
C: -0.9%
OPNT | $20.65 -0.58% 0.48% 0
|
Health Technology
|
| O: -1.51%
H: 8.43%
C: -1.53%
opnt002 alcohol pharmaceuticals trial phase 2
Athira Puts Optimistic Subgroup Spin on Failed Alzheimer's Trial
Published: 2022-06-22 (Crawled : 15:20) - biospace.com/
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -0.6%
H: 5.96%
C: 1.4%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -2.59%
H: 2.19%
C: 1.04%
alzheimer's trial
Athira Puts Positive Spin on Alzheimer’s Trial Despite Missed Endpoint
Published: 2022-06-22 (Crawled : 14:20) - biospace.com/
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -0.6%
H: 5.96%
C: 1.4%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -2.59%
H: 2.19%
C: 1.04%
trial alzheimer’s positive alzheimer's
Seanergy and NYK Line Announce Successful Completion of Biofuel Trials on a Capesize Vessel
Published: 2022-03-16 (Crawled : 09:00) - globenewswire.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -0.36%
H: 6.42%
C: 0.77%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: 3.96%
H: 3.26%
C: 2.47%
SHIP | $9.47 1.61% 1.58% 230K
|
Miscellaneous
|
| O: 2.73%
H: 4.42%
C: 3.54%
als trials trial success
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.